Bulis Veronica Sanchez 4
4 · Lyell Immunopharma, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Bulis Veronica Sanchez
VP, Corporate Controller
Transactions
- Sale
Common Stock
2025-12-24$38.67/sh−1,136$43,929→ 8,077 total - Sale
Common Stock
2025-12-30$32.32/sh−936$30,252→ 7,141 total
Footnotes (1)
- [F1]The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $38.6643 to $38.6751 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.